Objective: To investigate the efficacy and action mechanism of Shengjing Tablets in the treatment liquefaction.
Methods: We randomly assigned 150 patients with semen non-liquefaction to receive Shengjing Tablets group, n = 100) and vitamin E capsules (control group, n = 50) for 2 courses of 45 days each, followed by observation liquefaction time and other semen parameters.
Results: After the first course, 68 of the patients in the treatment group 20 responded and 12 failed to respond; and after the second course, 84 were cured, 9 responded and 7 failed to respond, effective rate of 93.0%. In comparison, only 8 of the controls were cured, 8 responded and 34 failed to respond after medication. There were statistically significant differences between the two groups (P < 0.01). Meanwhile, the treatment showed obvious improvement in sperm motility and concentration.
Conclusion: Shengjing Tablets may shorten the time liquefaction, and can be used as a safe and effective therapy for semen non-liquefaction.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Herb-separated moxibustion on navel combined with capsule for non-liquefaction semen with dampness and heat diffusing downward: a randomized controlled trial].
Zhongguo Zhen Jiu
December 2021
College of Acupuncture-Moxibustion and Tuina, Shandong University of TCM, Jinan 250355, China.
Article Synopsis
- The study aimed to compare the effectiveness of herb-separated moxibustion combined with capsules to capsules alone in treating non-liquefaction semen with dampness and heat diffusing downward.
- A total of 66 patients were randomly assigned to either the observation group (with moxibustion) or the control group (capsules only), with both groups undergoing three treatment courses and evaluating semen quality and TCM syndrome scores pre- and post-treatment.
- Results showed significant improvements in the observation group for semen liquefaction time, sperm quality, and TCM scores, leading to higher therapeutic and pregnancy rates compared to the control group.
[Ningmitai Capsule for the treatment of andrological diseases: Advances in studies].
Zhonghua Nan Ke Xue
October 2017
Department of Andrology, Jinling Hospital Affiliated to Southern Medical University / Nanjing General Hospital of Nanjing Military Region, Nanjing, Jiangsu 210002, China;.
Ningmitai Capsule is a classical patent medicine prepared from multiple effective ingredients of Chinese herbal medicine, with a wide range of biological activities and a significant efficacy in the treatment of urogenital diseases. Ningmitai Capsule has been widely applied in the management of urological and andrological diseases, with a particularly ideal effect on chronic prostatitis, since its first introduction nearly 20 years ago. With no obvious adverse effect on the male reproductive system, it has also been gaining a gradual application in the treatment of such diseases as urinary tract infections, diabetes, non-gonococcal urethritis, seminal vesiculitis, acute epididymitis, overactive bladder, hematuria, and semen non-liquefaction.
View Article and Find Full Text PDFObjective: To observe the clinical effect of Gushenyutai plaster administered at the Guanyuan (CV 4) acupoint on male infertility associated with semen non-liquefaction.
Methods: Sixty-two male patients with infertility caused by semen non-liquefaction were randomized into a treatment and control group. The control group received comprehensive therapy, which included oral administration of clarithromycin sustained release tablets, hip bath with Zhongyaoxiaoyan granules, prostate massage, and transurethral microwave treatment.
[Shengjing tablets for semen non-liquefaction: a clinical study of 100 cases].
Zhonghua Nan Ke Xue
June 2012
Department of Andrology, The Third Hospital of Zhengzhou University, Henan, Zhengzhou 450052, China.
Objective: To investigate the efficacy and action mechanism of Shengjing Tablets in the treatment liquefaction.
Methods: We randomly assigned 150 patients with semen non-liquefaction to receive Shengjing Tablets group, n = 100) and vitamin E capsules (control group, n = 50) for 2 courses of 45 days each, followed by observation liquefaction time and other semen parameters.
Results: After the first course, 68 of the patients in the treatment group 20 responded and 12 failed to respond; and after the second course, 84 were cured, 9 responded and 7 failed to respond, effective rate of 93.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!